219 related articles for article (PubMed ID: 20668475)
1. Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.
Shi Y; Tomic J; Wen F; Shaha S; Bahlo A; Harrison R; Dennis JW; Williams R; Gross BJ; Walker S; Zuccolo J; Deans JP; Hart GW; Spaner DE
Leukemia; 2010 Sep; 24(9):1588-98. PubMed ID: 20668475
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.
Spaner DE
Front Immunol; 2021; 12():772304. PubMed ID: 34868034
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol has anti-leukemic activity associated with decreased O-GlcNAcylated proteins.
Tomic J; McCaw L; Li Y; Hough MR; Ben-David Y; Moffat J; Spaner DE
Exp Hematol; 2013 Aug; 41(8):675-86. PubMed ID: 23597602
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.
Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R
Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493
[TBL] [Abstract][Full Text] [Related]
5. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
[TBL] [Abstract][Full Text] [Related]
6. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
7. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
8. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells.
Grandjenette C; Kennel A; Faure GC; Béné MC; Feugier P
Haematologica; 2007 Sep; 92(9):1279-81. PubMed ID: 17768129
[TBL] [Abstract][Full Text] [Related]
9. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
10. TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib.
Dadashian EL; McAuley EM; Liu D; Shaffer AL; Young RM; Iyer JR; Kruhlak MJ; Staudt LM; Wiestner A; Herman SEM
Cancer Res; 2019 Jan; 79(2):360-371. PubMed ID: 30498085
[TBL] [Abstract][Full Text] [Related]
11. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
12. O-linked N-acetylglucosamine (O-GlcNAc) protein modification is increased in the cartilage of patients with knee osteoarthritis.
Tardio L; Andrés-Bergós J; Zachara NE; Larrañaga-Vera A; Rodriguez-Villar C; Herrero-Beaumont G; Largo R
Osteoarthritis Cartilage; 2014 Feb; 22(2):259-63. PubMed ID: 24333294
[TBL] [Abstract][Full Text] [Related]
13. The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli.
Martinelli S; Maffei R; Fiorcari S; Quadrelli C; Zucchini P; Benatti S; Potenza L; Luppi M; Marasca R
Leuk Res; 2017 Mar; 54():17-24. PubMed ID: 28092772
[TBL] [Abstract][Full Text] [Related]
14. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
[TBL] [Abstract][Full Text] [Related]
16. Impaired O-linked N-acetylglucosaminylation in the endoplasmic reticulum by mutated epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine transferase found in Adams-Oliver syndrome.
Ogawa M; Sawaguchi S; Kawai T; Nadano D; Matsuda T; Yagi H; Kato K; Furukawa K; Okajima T
J Biol Chem; 2015 Jan; 290(4):2137-49. PubMed ID: 25488668
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia.
Spaner DE; Masellis A
Leukemia; 2007 Jan; 21(1):53-60. PubMed ID: 17066089
[TBL] [Abstract][Full Text] [Related]
18. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling.
Zou L; Yang S; Champattanachai V; Hu S; Chaudry IH; Marchase RB; Chatham JC
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H515-23. PubMed ID: 19098112
[TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
Hammadi A; Billard C; Faussat AM; Kolb JP
Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
